Pharmacokinetic Bioequivalence Studies of a New Etoricoxib Tablet Formulation Developed Using Proprietary MiST Technology — Risk Assessment and Mitigation Using GastroPlus Software
Generics and Biosimilars Initiative Journal(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要